Ole has more than 25 years executive experience in the pharma and biotech industry. He has prepared and negotiated numerous licensing and collaboration deals at all levels and is the co-founder of five companies in the life science/medtech field. In 2016 he co-founded and led the medtech company Cura Nordic until a successful exit in 2018 by way of an asset deal to Karo Pharma AB in Sweden